u/tanrock2003

HELP Q2 filings show strong institutional accumulation, though no evidence of access to blinded Phase 3 data.

Adage Capital increased from 700K to 3.06M shares (3.29M incl. warrants, 5.29% ownership). Other new/increased holders include SIO (1.3M), Logos (750K), DCF (743K), Sphera (~634K), Nan Fung (~527K), Rosalind (425K), and Boxer (150K), totaling ~6.9M shares added.

Fintel shows institutional longs up ~2.62M shares (+8.95%), with 63 buyers vs 14 sellers. Notable trims: Sirenia (down 648K common, still long warrants), OrbiMed (still 3.27M), Deep Track exited common.

Warrants: June raise was common-only; $8.14 warrants came from Oct 2025 financing. 189K were exercised on Aug 10 (~$1.54M), leaving ~9.22M outstanding.

This morning strengthened the pre-Phase III HELP thesis on two fronts.

Recent ownership filings show meaningful institutional accumulation occurring behind the scenes, including Adage Capital crossing the 5% threshold with 3.29 million shares, alongside substantial positions from sophisticated healthcare and hedge-fund investors such as OrbiMed, Venrock, Millennium and Eventide. This helps explain some of the recent share-price appreciation as institutional investors increasingly underwrite the probability of a successful APPROACH readout rather than simply speculative retail momentum.

Today’s financial update was equally constructive. APPROACH enrollment is complete, Q4 2026 topline guidance remains unchanged, EMBRACE and EXTEND continue advancing, and the completed DDI study further supports HLP003’s commercial positioning as an adjunct to existing antidepressants. Helus ended June with $166.4 million in cash following its $50 million institutional financing, substantially reducing pre-readout financing risk.

Taken together, there is no evident deterioration in the clinical thesis, timeline or financial position. Instead, institutional ownership is becoming more visible, the balance sheet is well funded through the pivotal catalyst, and management continues executing toward the Q4 Phase III readout.

Let’s fucking go!

This is entirely speculative, and I want to make that clear from the outset. I have seen nothing suggesting that Auxly Cannabis Group or Imperial Brands is preparing a bid for Aurora Cannabis, nor am I suggesting that such a transaction is currently being discussed. What I am looking at is the strategic logic created by Curaleaf’s announced intention to acquire Aurora and asking what it might mean for other companies in the sector.

The most interesting part of Curaleaf’s proposed Aurora acquisition is not simply the US$4.00-per-share offer. It is the reasoning Curaleaf has given for wanting Aurora in the first place. Aurora possesses substantial EU-GMP cultivation and manufacturing capacity, a significant international medical cannabis business, established operations across Europe and other international markets, and more than 50 tonnes of annual EU-GMP production capacity. Curaleaf sees value in combining those assets with its own processing, distribution and international commercial infrastructure.

That immediately raises an interesting question regarding Auxly and its longstanding strategic relationship with Imperial Brands.

Imperial already owns approximately 20% of Auxly and has been associated with the company for years. Auxly, meanwhile, is a very different company today from the financially distressed cannabis operator it was several years ago. Its profitability has improved considerably, its balance sheet has strengthened, its Leamington operation provides significant production capacity, and management has begun talking more openly about developing international export capabilities.

Imperial Brands adds an entirely different dimension to that story.

Imperial is one of the world’s major tobacco and consumer nicotine companies. It has enormous financial resources, global commercial experience and established distribution capabilities. At the same time, Imperial is restructuring its traditional tobacco operations, cutting thousands of jobs and targeting hundreds of millions of pounds in annual savings. Importantly, that restructuring does not appear to mean Imperial has stopped investing. The company recently agreed to acquire Black Buffalo for US$150 million upfront, with additional consideration tied to performance. That transaction demonstrates that Imperial remains willing to deploy capital toward strategically attractive businesses outside its traditional combustible cigarette operations.

That is why I think it is worth looking at Auxly differently.

The immediate objection to any discussion of Auxly acquiring something like Aurora is obvious: Auxly itself is far too small to fund a transaction of that magnitude from its current balance sheet.

That is true.

However, Auxly would not necessarily have to finance a transformational acquisition entirely on its own.

Imperial could theoretically remain at approximately its current 20% ownership of Auxly while supporting a larger transaction through other financial structures. There are numerous ways large strategic shareholders can participate economically without simply purchasing additional common shares and taking majority control. Acquisition financing could potentially involve a subsidiary, a separate acquisition company, debt, preferred capital, guarantees, joint ownership of certain assets or other corporate structures.

I am not suggesting that any particular structure is being considered. The point is simply that Imperial maintaining roughly 20% ownership of Auxly does not automatically prevent Auxly from becoming substantially larger.

Conceptually, you could have Imperial Brands continuing as a major strategic shareholder in Auxly while Auxly operates the Canadian cannabis business and a subsidiary or international division owns acquired international assets.

In the case of Aurora specifically, I would not necessarily envision someone buying Aurora simply to shut its facilities down and move all production to Auxly’s Leamington operation. That would defeat part of the purpose of acquiring Aurora.

Aurora’s international infrastructure is one of its most valuable strategic assets.

A more logical combination would preserve Aurora’s EU-GMP manufacturing and medical cannabis infrastructure while integrating Canadian production where efficiencies could be achieved. Auxly’s Leamington facility could potentially serve as a highly efficient Canadian production platform, while Aurora’s international operations could provide the regulatory, medical and distribution infrastructure required to access overseas markets.

In that type of structure, Leamington could serve as a major Canadian production hub while Aurora’s existing international infrastructure provides access to Europe and other medical markets. Auxly would remain the operating cannabis company, while Imperial would remain a significant strategic shareholder with considerable financial and commercial resources behind it.

That is a much more interesting way of thinking about Auxly than simply viewing it as another small Canadian licensed producer.

There is also a broader possibility that may ultimately prove more important than Aurora itself.

Perhaps Curaleaf ultimately acquires Aurora and no competing offer ever appears. That would not make this exercise irrelevant. The Curaleaf transaction could still establish an important valuation benchmark for cannabis assets.

For years, cannabis M&A was largely characterized by financially weak companies buying other financially weak companies, often using inflated stock prices and questionable assumptions about future growth. Many of those transactions destroyed shareholder value.

What may now be emerging is something quite different.

Strategic buyers may increasingly compete for profitable companies, efficient production facilities, international licences, EU-GMP infrastructure, medical distribution networks and established brands.

If that happens, the value of the remaining high-quality cannabis assets could begin to be viewed very differently.

Auxly potentially fits into that discussion because it combines increasingly profitable operations, scalable production, established Canadian brands, improving financial strength and a major strategic shareholder in Imperial Brands.

Imperial has already invested heavily in Auxly. It has maintained approximately a 20% ownership position, helped restructure the historical debt relationship and continues to have a strategic relationship with the company. At the same time, Auxly itself has begun discussing international expansion.

Meanwhile, Imperial is restructuring its traditional tobacco operations, extracting substantial cost savings and demonstrating through transactions such as Black Buffalo that it remains willing to acquire businesses that fit its longer-term strategy.

None of this means Imperial is suddenly preparing to spend billions of dollars on cannabis.

It does, however, raise an important question.

If Imperial eventually decides that cannabis has matured enough to justify allocating significantly more capital to the sector, would it make more sense to build around Auxly — a company in which it already owns approximately 20% and has an established strategic relationship — rather than starting from scratch?

If the answer is yes, then Auxly could potentially become a much larger consolidation vehicle than its current market capitalization would suggest.

That is why I think Curaleaf’s move on Aurora deserves attention even from Auxly shareholders.

The specific outcome of the Aurora transaction is important, but the larger development may be that cannabis consolidation is finally beginning to change character. Instead of distressed companies trading assets among themselves, we may be entering a period where stronger operators and strategic investors begin competing for the relatively small number of high-quality cannabis platforms that remain.

If that happens, the relationship between Auxly and Imperial Brands becomes increasingly difficult to ignore.

Again, this is speculation rather than a prediction. There is currently no evidence that Auxly or Imperial Brands is preparing a bid for Aurora.

But if cannabis M&A is entering a new phase, Auxly’s relationship with Imperial gives it strategic optionality that may not be obvious simply by looking at Auxly’s current market capitalization or cash balance.

Ugly day, no question. Down about 14% after running from the $7s to almost $12 in a very short period. But I don’t think the bigger picture changed much. This looked more like a hard momentum flush than some fundamental breakdown: failed push at $12, profit-taking, stops getting hit, short-term traders bailing, and probably some option-related hedging effects with the August expiry coming up.

There’s also a reasonable possibility that some warrant holders exercised around the $8.14 strike and sold shares into the strength. If that happened, it would add temporary supply without necessarily meaning those investors are bearish. They could easily monetize the shares and keep Q4 upside through December calls or other positions.

Technically, the stock finally got the reset it probably needed after going almost straight up.

https://preview.redd.it/aeikqksr8mdh1.png?width=1752&format=png&auto=webp&s=76269a3d3c4af59bacbfe144ea0d83519118b47f

Looking for feedback from other Searwood owners who have encountered an E04 Communication Failure error.
I picked up a brand-new Searwood XL 600 on Sunday. Assembly went smoothly, connected it to Weber Connect, after updating to the latest firmware through the Weber Connect app, completed the initial setup, and successfully completed my first cook without any issues.
The problem started yesterday updating to the latest firmware through the Weber Connect app. The grill powers on, displays the normal startup screen for a few seconds, and then immediately flashes E04 Communication Failure. Nothing else happens. The fan, auger, and igniter never begin their startup sequence.

Here is everything I’ve tried so far:

1. Unplugged the grill and left it unplugged for extended periods.
2. Held the power button while unplugged to discharge residual power.
3. Held the power button while restoring power in an attempt to force a reset/recovery.
4. Removed the grill from the Weber Connect app.
5. Deleted and reinstalled the app.
6. Checked all visible wiring connections.
7. Reseated all accessible wiring connectors.
8. Removed temperature probes.
9. Plugged directly into a wall outlet.
10. Confirmed there has been no rain, moisture exposure, washing, or water intrusion.

I also contacted Weber support. They had me remove the access panel and inspect the electronics while the grill was powered. They instructed me to look for:

1. One solid green light
2. One flashing green light

What I found was:

1. One solid green light present
2. No flashing green light at all

At this point, Weber has escalated the case.

My questions for other Searwood owners has anyone experienced an E04 Communication Failure after a firmware update? Is there a firmware recovery or forced reflash procedure that Weber support may not have mentioned? Does the missing flashing green light indicate a failed controller board or main control board? Have I exhausted the normal troubleshooting steps, or is there something else I should try before replacement parts are involved?

Given that the grill worked perfectly before the firmware update and now immediately throws E04 on startup, I’m starting to think this is either a firmware corruption issue or a failed control board. Any insight would be appreciated.

**If someone from Weber’s engineering team happens to read this:

The grill successfully completed a cook before the firmware update. The E04 error first appeared only after the firmware update process and has been present on every startup since. That timing seems unlikely to be coincidental.

This is the kind of press release that doesn’t excite retail no flashy numbers, no immediate catalyst but it absolutely checks boxes for institutional DD. Helus Pharma is telegraphing the move from “experimental biotech” toward an integrated neuro-therapeutics platform. That shift is subtle, but it’s exactly where companies start to become buyable, not just interesting. This isn’t something that moves the stock it’s a quiet brick being laid in a longer-term buyout case.